[
  {
    "ts": null,
    "headline": "Danaher Announces Quarterly Dividend",
    "summary": "Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026.",
    "url": "https://finnhub.io/api/news?id=9281c5c96186aad925566ac245d7ed82bb5dce3c0aa9594192b1e74e5ac84b2c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771968600,
      "headline": "Danaher Announces Quarterly Dividend",
      "id": 139201672,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026.",
      "url": "https://finnhub.io/api/news?id=9281c5c96186aad925566ac245d7ed82bb5dce3c0aa9594192b1e74e5ac84b2c"
    }
  },
  {
    "ts": null,
    "headline": "Danaher to Present at TD Cowen Health Care Conference",
    "summary": "Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 3, 2025 at 1:50 p.m. ET. The event will be simultaneously webcast and can be accessed on the \"Investors\" section of Danaher's website, www.danaher.com, under the subheading \"Events & Presentations.\"",
    "url": "https://finnhub.io/api/news?id=b103ab190500063c280ec2b23f2c7883e4c276e9de6757a1e790ed840f4d1a6e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771967100,
      "headline": "Danaher to Present at TD Cowen Health Care Conference",
      "id": 139201673,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 3, 2025 at 1:50 p.m. ET. The event will be simultaneously webcast and can be accessed on the \"Investors\" section of Danaher's website, www.danaher.com, under the subheading \"Events & Presentations.\"",
      "url": "https://finnhub.io/api/news?id=b103ab190500063c280ec2b23f2c7883e4c276e9de6757a1e790ed840f4d1a6e"
    }
  },
  {
    "ts": null,
    "headline": "All-Cash Masimo Deal Offers Strong Strategic Fit For Danaher Corporation (DHR)",
    "summary": "Danaher Corporation (NYSE:DHR) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 17, Danaher Corporation (NYSE:DHR) announced an agreement to acquire Masimo Corporation (NASDAQ:MASI) for nearly $9.9 billion. In the all-cash deal, Danaher will acquire 100% of the common shares outstanding at $180 per share. This translates […]",
    "url": "https://finnhub.io/api/news?id=a27da791f9b608c8cdea6b5e198c4d0f99739dfef9cbfa914c71633d13cc631c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771961516,
      "headline": "All-Cash Masimo Deal Offers Strong Strategic Fit For Danaher Corporation (DHR)",
      "id": 139200990,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher Corporation (NYSE:DHR) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 17, Danaher Corporation (NYSE:DHR) announced an agreement to acquire Masimo Corporation (NASDAQ:MASI) for nearly $9.9 billion. In the all-cash deal, Danaher will acquire 100% of the common shares outstanding at $180 per share. This translates […]",
      "url": "https://finnhub.io/api/news?id=a27da791f9b608c8cdea6b5e198c4d0f99739dfef9cbfa914c71633d13cc631c"
    }
  },
  {
    "ts": null,
    "headline": "Masimo Buyout By Danaher Spurs Revaluation And Volatility Questions",
    "summary": "Danaher Corporation has agreed to acquire Masimo Corporation, positioning Masimo as a standalone business within Danaher's Diagnostics segment. The transaction has been unanimously approved by both companies' boards. Masimo trades on the NasdaqGS under the ticker NasdaqGS:MASI, with a recent share price of $175.25. For you as an investor, this deal connects Masimo, a med tech player, with a large industry buyer that intends to keep it as a focused diagnostics business. The stock has...",
    "url": "https://finnhub.io/api/news?id=5b63209f0baa1927126d5fd4fbabbce8c2bf7d61d8571ac246e058079fabf924",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771949479,
      "headline": "Masimo Buyout By Danaher Spurs Revaluation And Volatility Questions",
      "id": 139198935,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher Corporation has agreed to acquire Masimo Corporation, positioning Masimo as a standalone business within Danaher's Diagnostics segment. The transaction has been unanimously approved by both companies' boards. Masimo trades on the NasdaqGS under the ticker NasdaqGS:MASI, with a recent share price of $175.25. For you as an investor, this deal connects Masimo, a med tech player, with a large industry buyer that intends to keep it as a focused diagnostics business. The stock has...",
      "url": "https://finnhub.io/api/news?id=5b63209f0baa1927126d5fd4fbabbce8c2bf7d61d8571ac246e058079fabf924"
    }
  },
  {
    "ts": null,
    "headline": "Danaher (DHR) is Gaining from Improvement in Its Bioprocessing Business",
    "summary": "Madison Investments, an investment advisor, released its fourth-quarter 2025 investor letter for the “Madison Large Cap Fund”. A copy of the letter can be downloaded here. In the fourth quarter, the S&P 500 returned 2.65%, resulting in a full-year return of 17.9% for 2025. Over the last three years, the Index has achieved annual growth of […]",
    "url": "https://finnhub.io/api/news?id=138ce19e3bfc94177872d97f8e8b22c1cecfa08ea3e9a2af6244eeea6643b5cc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771940039,
      "headline": "Danaher (DHR) is Gaining from Improvement in Its Bioprocessing Business",
      "id": 139194521,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Madison Investments, an investment advisor, released its fourth-quarter 2025 investor letter for the “Madison Large Cap Fund”. A copy of the letter can be downloaded here. In the fourth quarter, the S&P 500 returned 2.65%, resulting in a full-year return of 17.9% for 2025. Over the last three years, the Index has achieved annual growth of […]",
      "url": "https://finnhub.io/api/news?id=138ce19e3bfc94177872d97f8e8b22c1cecfa08ea3e9a2af6244eeea6643b5cc"
    }
  },
  {
    "ts": null,
    "headline": "Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics",
    "summary": "By 2033, the Point of Care (POC) Diagnostics market is projected to reach a valuation of approximately US$ 105.22 billion, driven by an 8.60% CAGR from 2025. This robust growth is fueled by high demand for rapid and accessible testing, escalating global prevalence of infectious diseases, and breakthroughs in technology. POC diagnostics facilitate immediate results at patient care sites, enhancing clinical decision-making and patient outcomes. Key players leading this market, including Sysmex, Ab",
    "url": "https://finnhub.io/api/news?id=c7dee46660dfb88617b19fd30ff9810656dc2e7d7bb58811acd4694555d9bad7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771932960,
      "headline": "Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics",
      "id": 139193296,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "By 2033, the Point of Care (POC) Diagnostics market is projected to reach a valuation of approximately US$ 105.22 billion, driven by an 8.60% CAGR from 2025. This robust growth is fueled by high demand for rapid and accessible testing, escalating global prevalence of infectious diseases, and breakthroughs in technology. POC diagnostics facilitate immediate results at patient care sites, enhancing clinical decision-making and patient outcomes. Key players leading this market, including Sysmex, Ab",
      "url": "https://finnhub.io/api/news?id=c7dee46660dfb88617b19fd30ff9810656dc2e7d7bb58811acd4694555d9bad7"
    }
  }
]